Asymmetric gating of a human hetero-pentameric glycine receptor.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
11 10 2023
Historique:
received: 16 12 2022
accepted: 28 09 2023
medline: 23 10 2023
pubmed: 12 10 2023
entrez: 11 10 2023
Statut: epublish

Résumé

Hetero-pentameric Cys-loop receptors constitute a major type of neurotransmitter receptors that enable signal transmission and processing in the nervous system. Despite intense investigations into their working mechanism and pharmaceutical potentials, how neurotransmitters activate these receptors remains unclear due to the lack of high-resolution structural information in the activated open state. Here we report near-atomic resolution structures resolved in digitonin consistent with all principle functional states of the human α1β GlyR, which is a major Cys-loop receptor that mediates inhibitory neurotransmission in the central nervous system of adults. Glycine binding induces cooperative and symmetric structural rearrangements in the neurotransmitter-binding extracellular domain but asymmetrical pore dilation in the transmembrane domain. Symmetric response in the extracellular domain is consistent with electrophysiological data showing cooperative glycine activation and contribution from both α1 and β subunits. A set of functionally essential but differentially charged amino acid residues in the transmembrane domain of the α1 and β subunits explains asymmetric activation. These findings provide a foundation for understanding how the gating of the Cys-loop receptor family members diverges to accommodate specific physiological environments.

Identifiants

pubmed: 37821459
doi: 10.1038/s41467-023-42051-6
pii: 10.1038/s41467-023-42051-6
pmc: PMC10567788
doi:

Substances chimiques

Receptors, Glycine 0
Cysteine Loop Ligand-Gated Ion Channel Receptors 0
Glycine TE7660XO1C

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6377

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2023. Springer Nature Limited.

Références

J Child Neurol. 2013 Jan;28(1):90-4
pubmed: 22532536
J Clin Invest. 2016 Jul 1;126(7):2547-60
pubmed: 27270175
Elife. 2022 Aug 17;11:
pubmed: 35975975
Biochim Biophys Acta Biomembr. 2021 Mar 1;1863(3):183533
pubmed: 33340490
Nature. 2015 Oct 8;526(7572):224-9
pubmed: 26344198
Nat Genet. 1993 Dec;5(4):351-8
pubmed: 8298642
J Physiol. 2020 Oct;598(20):4643-4661
pubmed: 32844405
EMBO J. 1993 Oct;12(10):3729-37
pubmed: 8404844
Mol Brain. 2014 Jan 09;7:2
pubmed: 24405574
Neuron. 2021 Sep 1;109(17):2707-2716.e6
pubmed: 34473954
Nat Commun. 2020 Jul 27;11(1):3752
pubmed: 32719334
Biophys J. 1993 Dec;65(6):2455-60
pubmed: 7508762
Neuropharmacology. 2009 Jan;56(1):303-9
pubmed: 18721822
J Mol Graph. 1996 Dec;14(6):354-60, 376
pubmed: 9195488
Neuron. 2020 Jun 17;106(6):952-962.e5
pubmed: 32275860
Nat Neurosci. 2014 Feb;17(2):232-9
pubmed: 24390226
Physiol Rev. 2012 Jul;92(3):1189-234
pubmed: 22811427
Cell. 2021 Feb 18;184(4):957-968.e21
pubmed: 33567265
Nat Methods. 2014 Jan;11(1):63-5
pubmed: 24213166
Biomolecules. 2021 Jun 06;11(6):
pubmed: 34204137
Nat Commun. 2023 Mar 13;14(1):1363
pubmed: 36914669
Protein Expr Purif. 2014 Mar;95:240-7
pubmed: 24480187
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Structure. 2017 Jun 6;25(6):945-950.e2
pubmed: 28479061
Mol Psychiatry. 2011 Aug;16(8):867-80
pubmed: 20479760
J Struct Biol. 2015 Nov;192(2):216-21
pubmed: 26278980
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Q Rev Biophys. 2010 Nov;43(4):449-99
pubmed: 20849671
Nat Commun. 2021 Feb 16;12(1):1074
pubmed: 33594077
Nature. 2014 Dec 4;516(7529):126-30
pubmed: 25471887
Front Cell Neurosci. 2013 Oct 21;7:184
pubmed: 24155690
Proc Natl Acad Sci U S A. 2023 May 2;120(18):e2302325120
pubmed: 37098056
Elife. 2015 Dec 01;4:
pubmed: 26623517
Behav Genet. 1995 Mar;25(2):149-59
pubmed: 7733856
J Child Neurol. 2008 Dec;23(12):1433-8
pubmed: 19073849
Structure. 2020 Jun 2;28(6):690-693.e3
pubmed: 32492413
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
Proc Natl Acad Sci U S A. 1988 Oct;85(19):7394-8
pubmed: 2459705
Nat Struct Mol Biol. 2017 Feb;24(2):108-113
pubmed: 27991902
Neuron. 2015 Jun 3;86(5):1119-30
pubmed: 26050032
Neuron. 1993 Dec;11(6):1049-56
pubmed: 8274276
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
EMBO J. 2004 Jul 7;23(13):2510-9
pubmed: 15201864
Nature. 2021 Nov;599(7885):513-517
pubmed: 34555840
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
EMBO J. 1992 Dec;11(12):4305-11
pubmed: 1385113
Nature. 2015 Oct 8;526(7572):277-80
pubmed: 26416729
Nat Commun. 2015 Apr 20;6:6829
pubmed: 25891813
Cell. 2021 Apr 15;184(8):2121-2134.e13
pubmed: 33735609
Neuron. 1992 Dec;9(6):1155-61
pubmed: 1281418
Neuron. 2016 May 4;90(3):452-70
pubmed: 27151638
Nat Commun. 2022 Jun 9;13(1):3232
pubmed: 35680900
Nat Methods. 2020 Dec;17(12):1214-1221
pubmed: 33257830
Cell. 2021 Jan 21;184(2):370-383.e13
pubmed: 33333023
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
Elife. 2020 Oct 16;9:
pubmed: 33063666
Cell. 2022 Jul 7;185(14):2469-2477.e13
pubmed: 35803245
Nature. 1993 Dec 23-30;366(6457):745-8
pubmed: 8264797
Neuron. 1995 Sep;15(3):563-72
pubmed: 7546736
Chem Rev. 2012 Dec 12;112(12):6334-52
pubmed: 22607259
Physiol Rev. 2004 Oct;84(4):1051-95
pubmed: 15383648
Curr Opin Investig Drugs. 2006 Jan;7(1):48-53
pubmed: 16425671
Nat Protoc. 2014 Nov;9(11):2574-85
pubmed: 25299155
Neuron. 2013 Jan 23;77(2):259-73
pubmed: 23352163
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701

Auteurs

Xiaofen Liu (X)

Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Weiwei Wang (W)

Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, USA. Weiwei.Wang@UTSouthwestern.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH